Drug developers will now have enhanced abilities to rapidly prototype, test, iterate, and scale up their mRNA therapeutics.

Improvements in our understanding of the human genome, technological tools like artificial intelligence, and global ...

Five researchers have been jointly awarded one of this year's Breakthrough Prizes in Life Sciences for their contributions to the development of Ozempic-style drugs.

Considering that PD-1/L1 are some of the most lucrative drug treatments across the industry, this could be a major coup for any mRNA developer that manages to successfully co-develop such a treatment.

South Korean researchers have, for the first time in the world, uncovered how messenger ribonucleic acid (mRNA) vaccines ...

Kennedy Jr. has alluded to in the past, this could have major repercussions for vaccine developers. Companies like Moderna (NASDAQ:MRNA) spend years playing by the rules of the FDA. If authorities ...

Related: Scientists behind tech in mRNA vaccines snag 2nd prestigious prize — is a Nobel next? Holst and his colleagues received one of the life-science awards this year "for the discovery and ...

They could also offer a more potent option to conventional flu shots, according to mRNA vaccine developers. Current flu vaccines generally offer only around 40% to 60% protective efficacy ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Novavax (NVAX), and BioNTech (BNTX) (BTNX), and gene therapy developers, including Sarepta (SRPT), Solid Biosciences (SLDB), Taysha Gene Therapies (TSHA), Capricor Therapeutics (CAPR), and Crispr ...